interleukin-6 mutein (ImClone)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameinterleukin-6 mutein (ImClone)
Drug Alias NameIL-6m (ImClone)FCE-27809
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionIL-6 receptor agonistsInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptorIL-6 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImclone Systems
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImclone Systems
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A